INTERNATIONAL PATENT: ZHANG, ZUOGUANG, 张作光 FILES APPLICATION FOR "USE OF IDO1 INHIBITOR ALBIFLORIN OR/AND PAEONIFLORIN IN IMMUNOTHERAPY FOR CANCER COMORBID WITH DEPRESSION"

GENEVA, May 17 -- ZHANG, Zuoguang (807, Building 30, MinwangyuanDongcheng District, Beijing 100000), 张作光 (中国北京市东城区民旺园30号楼807号) filed a patent application (PCT/CN2024/130710) for "USE OF IDO1 INHIBITOR ALBIFLORIN OR/AND PAEONIFLORIN IN IMMUNOTHERAPY FOR CANCER COMORBID WITH DEPRESSION" on Nov 08, 2024. With publication no. WO/2026/097395, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Zuoguang (807...